Literature DB >> 23218522

Hemiplegic shoulder pain: evidence of a neuropathic origin.

Gabi Zeilig1, Michal Rivel, Harold Weingarden, Evgeni Gaidoukov, Ruth Defrin.   

Abstract

Hemiplegic shoulder pain (HSP) is common after stroke. Whereas most studies have concentrated on the possible musculoskeletal factors underlying HSP, neuropathic aspects have hardly been studied. Our aim was to explore the possible neuropathic components in HSP, and if identified, whether they are specific to the shoulder or characteristic of the entire affected side. Participants included 30 poststroke patients, 16 with and 14 without HSP, and 15 healthy controls. The thresholds of warmth, cold, heat-pain, touch, and graphesthesia were measured in the intact and affected shoulder and in the affected lower leg. They were also assessed for the presence of allodynia and hyperpathia, and computed tomography/magnetic resonance imaging scans of the brain were reviewed. In addition, chronic pain was characterized. Participants with HSP exhibited higher rates of parietal lobe damage (P<0.05) compared to those without HSP. Both poststroke groups exhibited higher sensory thresholds than healthy controls. Those with HSP had higher heat-pain thresholds in both the affected shoulder (P<0.001) and leg (P<0.01), exhibited higher rates of hyperpathia in both these regions (each P<0.001), and more often reported chronic pain throughout the affected side (P<0.001) than those without HSP. The more prominent sensory alterations in the shoulder region suggest that neuropathic factors play a role in HSP. The clinical evidence of damage to the spinothalamic-thalamocortical system in the affected shoulder and leg, the presence of chronic pain throughout the affected side, and the more frequent involvement of the parietal cortex all suggest that the neuropathic component is of central origin.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23218522     DOI: 10.1016/j.pain.2012.10.026

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  7 in total

Review 1.  Updates in the Treatment of Post-Stroke Pain.

Authors:  Alyson R Plecash; Amokrane Chebini; Alvin Ip; Joshua J Lai; Andrew A Mattar; Jason Randhawa; Thalia S Field
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

2.  Research Hotspots and Frontiers in Post Stroke Pain: A Bibliometric Analysis Study.

Authors:  Chong Li; Xiaoyi Shu; Xiangyun Liu
Journal:  Front Mol Neurosci       Date:  2022-05-13       Impact factor: 6.261

Review 3.  Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.

Authors:  Domenico Intiso; Mario Basciani; Andrea Santamato; Marta Intiso; Filomena Di Rienzo
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

4.  Prevalence and Management Challenges in Central Post-Stroke Neuropathic Pain: A Systematic Review and Meta-analysis.

Authors:  Andreas Liampas; Nikolaos Velidakis; Tiffany Georgiou; Athina Vadalouca; Giustino Varrassi; Georgios M Hadjigeorgiou; Georgios Tsivgoulis; Panagiotis Zis
Journal:  Adv Ther       Date:  2020-05-23       Impact factor: 3.845

Review 5.  Botulinum Toxin for Central Neuropathic Pain.

Authors:  Jihye Park; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2018-06-01       Impact factor: 4.546

6.  The Effects of Gender, Functional Condition, and ADL on Pressure Pain Threshold in Stroke Patients.

Authors:  Yong-Hui Zhang; Yu-Chen Wang; Gong-Wei Hu; Xiao-Qin Ding; Xiao-Hua Shen; Hui Yang; Ji-Feng Rong; Xue-Qiang Wang
Journal:  Front Neurosci       Date:  2021-07-30       Impact factor: 4.677

7.  Pain management of hemiplegic shoulder pain post stroke in patients from Nanjing, China.

Authors:  Yi Zhu; Bin Su; Ning Li; Hongzhu Jin
Journal:  Neural Regen Res       Date:  2013-09-05       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.